FI844230A0 - Enzyminhibition. - Google Patents

Enzyminhibition.

Info

Publication number
FI844230A0
FI844230A0 FI844230A FI844230A FI844230A0 FI 844230 A0 FI844230 A0 FI 844230A0 FI 844230 A FI844230 A FI 844230A FI 844230 A FI844230 A FI 844230A FI 844230 A0 FI844230 A0 FI 844230A0
Authority
FI
Finland
Prior art keywords
pct
sec
date
pub
enzyminhibition
Prior art date
Application number
FI844230A
Other languages
English (en)
Other versions
FI844230L (fi
FI88398C (fi
FI88398B (fi
Inventor
Michael Szelke
David Michael Jones
Martin Andrew Brydson
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of FI844230L publication Critical patent/FI844230L/fi
Publication of FI844230A0 publication Critical patent/FI844230A0/fi
Application granted granted Critical
Publication of FI88398B publication Critical patent/FI88398B/fi
Publication of FI88398C publication Critical patent/FI88398C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI844230A 1983-03-04 1984-10-29 Foerfarande foer framstaellning av peptidanaloger FI88398C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838305985A GB8305985D0 (en) 1983-03-04 1983-03-04 Enzyme inhibition
GB8305985 1983-03-04
PCT/GB1984/000063 WO1984003507A1 (en) 1983-03-04 1984-02-28 Enzyme inhibition
GB8400063 1984-02-28

Publications (4)

Publication Number Publication Date
FI844230L FI844230L (fi) 1984-10-29
FI844230A0 true FI844230A0 (fi) 1984-10-29
FI88398B FI88398B (fi) 1993-01-29
FI88398C FI88398C (fi) 1993-05-10

Family

ID=10538985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844230A FI88398C (fi) 1983-03-04 1984-10-29 Foerfarande foer framstaellning av peptidanaloger

Country Status (13)

Country Link
US (2) US4638047A (fi)
EP (1) EP0118280B1 (fi)
JP (1) JPS60500870A (fi)
AT (1) ATE44533T1 (fi)
AU (1) AU596783B2 (fi)
CA (1) CA1322078C (fi)
DE (1) DE3478928D1 (fi)
DK (1) DK520284A (fi)
ES (1) ES530262A0 (fi)
FI (1) FI88398C (fi)
GB (1) GB8305985D0 (fi)
IE (1) IE56958B1 (fi)
WO (1) WO1984003507A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4812442A (en) * 1984-05-29 1989-03-14 Merck & Co., Inc. Tripeptide renin inhibitors
DE3438545A1 (de) * 1984-10-20 1986-04-24 Merck Patent Gmbh, 6100 Darmstadt Peptide
DE3512128A1 (de) * 1985-04-03 1986-10-09 Merck Patent Gmbh, 6100 Darmstadt Peptide
US4705778A (en) * 1985-10-22 1987-11-10 Sri International Orally active LHRH analogs
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US4859654A (en) * 1987-07-01 1989-08-22 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US6313096B1 (en) 1988-04-28 2001-11-06 Trigen Limited Inhibitors of trypsin-like enzymes
US5574014A (en) * 1988-04-28 1996-11-12 Thrombosis Research Institute Inhibitors of trypsin-like enzymes
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1990013562A1 (en) * 1989-05-02 1990-11-15 Genelabs Incorporated Chemically modified cd4 peptide fragments having anti-retroviral properties
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
AU654820B2 (en) * 1990-06-15 1994-11-24 Majesty (Her) In Right Of Canada As Represented By The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
AU656947B2 (en) * 1991-02-04 1995-02-23 Akzo N.V. Factor IIa inhibitors
AU2548992A (en) * 1991-08-13 1993-03-16 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
DE69326069T2 (de) * 1992-07-20 2000-03-23 Univ Durham Zusammensetzungen die die hiv replikation inhibieren
US5637599A (en) * 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
GB9502985D0 (en) * 1995-02-16 1995-04-05 Thrombosis Res Inst Enzyme inhibitors
CN1198839C (zh) * 1995-02-17 2005-04-27 艾伯特有限及两合公司 作为凝血酶抑制剂的新的二肽脒类
DE69627191T2 (de) * 1995-06-09 2004-01-08 The Regents Of The University Of Michigan, Ann Arbor Bradikininanaloge als selektive thrombininhibitoren
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
BR9907112A (pt) 1998-01-26 2000-10-24 Basf Ag Composto, medicamento, e, uso de um composto
DE10254993A1 (de) * 2002-11-26 2004-06-09 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Säureamidarginine und deren Ester sowie deren Verwendung zur Konservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors

Also Published As

Publication number Publication date
CA1322078C (en) 1993-09-07
DK520284D0 (da) 1984-11-01
ES8602849A1 (es) 1985-12-01
IE56958B1 (en) 1992-02-12
JPS60500870A (ja) 1985-06-06
DK520284A (da) 1984-11-01
AU2651684A (en) 1984-09-28
US4638047A (en) 1987-01-20
WO1984003507A1 (en) 1984-09-13
GB8305985D0 (en) 1983-04-07
US4772686A (en) 1988-09-20
AU596783B2 (en) 1990-05-17
FI844230L (fi) 1984-10-29
ES530262A0 (es) 1985-12-01
FI88398C (fi) 1993-05-10
EP0118280B1 (en) 1989-07-12
IE840474L (en) 1984-09-04
EP0118280A1 (en) 1984-09-12
DE3478928D1 (en) 1989-08-17
ATE44533T1 (de) 1989-07-15
FI88398B (fi) 1993-01-29

Similar Documents

Publication Publication Date Title
FI844230A0 (fi) Enzyminhibition.
NO158250C (no) Leddarm-mekanisme.
NO851516L (no) Krysstang-kvadrupolkilde for akustisk broennlogging.
DE3480953D1 (de) Testverfahren.
FI844833A0 (fi) Antimikrobialiskt aemne foer latex.
NO156892C (no) Undervanns-propelldrift.
TR22859A (tr) Suebstituee edilmis 2,6,suebstituee piridin bilesikleri
DE3484655D1 (de) Neue derivative.
IT8422558A0 (it) Carburatore.
FI845140A0 (fi) Substituerade imidazoler.
IT8422711A0 (it) Procedimento per preparare proline sostituite.
DE3483342D1 (de) Entbeinungsvorrichtung.
DE68910526T2 (de) Mechanismus zur pulsationserzeugung für setzmaschine.
DE3482629D1 (de) Substituierte indole.
IT8424133A0 (it) Unita' di allacciamento.
IT8224380A0 (it) Amminoacidi fosfinilalcanoici utili come agenti ipotensivi.
NL192083B (nl) Orthopedische schoenenverbinder.
DE3850936T2 (de) Erzeugung von kontaktblöcken.
DE3486185T2 (de) Lichtemittierende halbleitervorrichtung.
FI843018A (fi) Preventiva foerfaranden.
DE3481537D1 (de) Verdichter.
KR850007924U (ko) 택(tack)
ATE33341T1 (de) Anordnung zum verbinden von zahnersatzteilen durch klebung.
ES263195Y (es) Fuente.
ATE31870T1 (de) Chirurgisches instrument zum anlegen von klammern.

Legal Events

Date Code Title Description
BB Publication of examined application
GB Transfer or assigment of application

Owner name: THROMBOSIS RESEARCH INSTITUTE

MM Patent lapsed
MM Patent lapsed

Owner name: THROMBOSIS RESEARCH INSTITUTE